Academician
ZİNNET ŞEVVAL AKSOYALP
Doçent
İzmir Katip Çelebi Üniversitesi Eczacılık Fakültesi Eczacılık Meslek Bilimleri Bölümü
- Gut microbiota and health6
- Diet and metabolism studies3
- Pharmacogenetics and Drug Metabolism3
- COVID-19 Clinical Research Studies2
- Diabetes Treatment and Management2
- CRISPR and Genetic Engineering2
- Metabolism, Diabetes, and Cancer2
- Tryptophan and brain disorders2
- Protein Degradation and Inhibitors2
- Pharmaceutical studies and practices2
- Pharmacovigilance and Adverse Drug Reactions2
- Cancer Genomics and Diagnostics1
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Tıbbi Farmakoloji
Citation impact
Citation counts of the articles matched in OpenAlex, citing publications from Crossref and the Stanford/Elsevier list. Sources are shown separately and never added up.
- i10-index
- 4
- Total citations
- 152 Top 30% in Türkiye
- Per article
- 6.1
- FWCI
- 1.24 1.00 = world average
- World top 1%
- 0
- World top 10%
- 5
Most cited articles
How is this computed?
h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included.
Citing publications Crossref 8 publications citing 26 DOI-bearing articles
- 2022 2
- 2025 6
- DOI 10.1186/s12906-025-05156-7 2025
- DOI 10.2147/ceor.s548758 2025
- DOI 10.1007/s00203-025-04556-0 2025
- DOI 10.1007/s00210-025-04548-3 2025 · cites 3 articles of this academic
- DOI 10.1016/bs.seda.2025.08.004 2025
- DOI 10.2147/cia.s531235 2025
- DOI 10.1101/2022.01.07.22268886 2022
- DOI 10.1007/s00432-022-03921-6 2022
Where does this list come from?
Extracted from the reference lists in Crossref’s public March 2026 data file; 20.3% of the file has been processed, so the list may be incomplete. Crossref citations are never added to or compared with the OpenAlex citation counts; the two sources have different coverage.
Field ranking
Position in the main-field, side-field and keyword cohorts by YÖKSİS article score; each card opens that ranking.
-
Main field Sağlık Bilimleri Temel AlanıPoints rank #12,327/ 39,749 top 31.0% At university #177/ 398Score 21.05 journal 19.8 · OA add 1.25
- Article rank17,367/39,749
- Scopus rank12,312/39,749
- WoS rank11,824/39,749
- YÖKSİS27
- Scopus23
- WoS23
-
Side field Tıbbi FarmakolojiPoints rank #144/ 392 top 36.7% At university #5/ 7Score 21.05 journal 19.8 · OA add 1.25
- Article rank195/392
- Scopus rank145/392
- WoS rank139/392
- YÖKSİS27
- Scopus23
- WoS23
Works 27
YÖKSİS and OpenAlex records: index distribution, journals published in, a filterable article list and the other output types.
Indexes and citation percentiles
?Other counts
Scopus (SJR)
- YÖKSİS rows 23
WoS (JCR)
- YÖKSİS rows 23
Articles
Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.
Journals with publications
23 journals
- Naunyn-Schmiedeberg's Archives of Pharmacology 5
- ISSN 1018-3655 1
- ISSN 2458-8938 1
- ISSN 2587-0335 1
- ISSN 2980-2156 1
- Advances in Medical Sciences 1
- Ankara Universitesi Eczacilik Fakultesi Dergisi 1
- Applied Radiation and Isotopes 1
- Current Medical Research and Opinion 1
- European Journal of Pharmacology 1
- EXCLI Journal 1
- Expert Opinion on Biological Therapy 1
- Folia Microbiologica 1
- Heart and Lung 1
- International Journal of Geriatric Psychiatry 1
- Journal of Cardiovascular Pharmacology 1
- Journal of Pharmaceutical Innovation 1
- Journal of Trace Elements in Medicine and Biology 1
- Life Sciences 1
- Nobel Medicus 1
- Pharmaceutical Research 1
- Turk Hijyen ve Deneysel Biyoloji Dergisi 1
- Turkish Journal of Pharmaceutical Sciences 1
Narrow down
Article list
- 2026 A year in pharmacology: new drugs approved by the US food and drug administration in 2025 YÖKSİS SJR Q2 JCR Q2 OpenAlex 17.5%
- 2026 Effects of empagliflozin and metformin on biofilm formation and pathogenicity factors of urinary Escherichia coli isolates YÖKSİS SJR Q2 JCR Q3 OpenAlex top 10% OpenAlex 95.1%
- 2026 A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) for therapeutic radiopharmaceuticals YÖKSİS SJR Q2 JCR Q2 OpenAlex 65.1%
- 2026 Disproportionality analysis of cardiovascular adverse events reported to the FDA adverse event monitoring system with monoclonal antibodies targeting type 2 inflammation YÖKSİS SJR Q2 JCR Q2
- 2026 The Consistency of “Do Not Swallow” Warning in Pharmaceutical Information Leaflets and Carton Labelling: A Cross-Sectional Study in Türkiye YÖKSİS SJR Q3 JCR Q3 OpenAlex 21.3%
- 2026 Diet-Derived Trimethylamine N-Oxide (TMAO) Pathway Disruption in Patients with Concurrent Alcohol Use Disorder and Smokers Persists After Alcohol Detoxification YÖKSİS JCR Q4 OpenAlex 44.0%
- 2025 Trimethylamine N-oxide as a potential prognostic biomarker for mortality in patients with COVID-19 disease YÖKSİS SJR Q2 JCR Q3 OpenAlex 62.3%
- 2025 A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2024 YÖKSİS SJR Q2 JCR Q2 OpenAlex top 10% OpenAlex 92.0%
- 2024 Comparative Post‐Marketing Surveillance of Memantine and Cholinesterase Inhibitors: Cardiovascular Adverse Events With a Focus on Sex Differences Using the FDA Adverse Event Reporting System Database YÖKSİS SJR Q1 JCR Q1 OpenAlex 86.8%
- 2024 A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2023 YÖKSİS SJR Q2 JCR Q2 OpenAlex 76.7%
- 2024 Pharmacological Innovations in Space: Challenges and Future Perspectives YÖKSİS SJR Q1 JCR Q1 OpenAlex 78.5%
- 2024 Chronotropic Responses to GLP-1 Receptor Agonists and Sitagliptin in Atria from Diabetic Rats YÖKSİS SJR Q2 JCR Q2 OpenAlex 66.8%
- 2024 Urinary Tract Infections and Fungal Infections Associated with SGLT-2 Inhibitors and Metformin Combination: A real-world study from 2013 to 2023 based on FAERS database YÖKSİS TR Index JCR Q4 OpenAlex 72.1%
- 2024 Comparative Evaluation of Artificial Intelligence and Drug Interaction Tools: A Perspective With The Example of Clopidogrel YÖKSİS SJR Q3 OpenAlex 65.9%
- 2024 A Preliminary Study on the Effect of Deferoxamine on Disruption of Bacterial Biofilms and Antimicrobial Resistance YÖKSİS TR Index SJR Q2 JCR Q3 OpenAlex 58.1%
- 2023 Optimization of enzyme-linked immunosorbent assay kit protocol to detect trimethylamine N-oxide levels in humans YÖKSİS SJR Q1 JCR Q1 OpenAlex 52.3%
- 2023 A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2022 YÖKSİS SJR Q2 JCR Q2 OpenAlex top 10% OpenAlex 90.7%
- 2023 Iron in infectious diseases friend or foe?: The role of gut microbiota YÖKSİS SJR Q1 JCR Q2 OpenAlex 85.5%
- 2022 A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2021 YÖKSİS SJR Q2 JCR Q2 OpenAlex top 10% OpenAlex 94.9%
- 2022 Koronavirüs Hastalığı 2019 (COVID-19)’da Gastrointestinal Belirtilerin Önemi ve Olası Mekanizmaları YÖKSİS OpenAlex 11.0%
Projects 3
-
2024 Enfeksiyonla Mücadelede İlaç Yeniden Konumlandırma: Empagliflozin ve Metforminin Antimikrobiyal Etki Potansiyellerinin Araştırılması
-
2020 2020-COV-ECZF-0004- COVID-19 Hastalarında Serum TMAO Düzeyi Erken Bir Biyobelirteç Olabilir mi?
-
2018 PAR-1 Antagonisti Vorapaksar ve Parmodulin-2’nin İnsan Sol İnternal Mammarian Arter Üzerindeki Fizyolojik Etkilerinin in vitro Karşılaştırılması
Books 7 See all (7) →
-
2026 Natural Products
-
2026 Reference Module in Biomedical Sciences
-
2024 Frontiers in Clinical Drug Research-Dementia Volume 3
-
2024 Studies in Natural Products Chemistry
-
2024 Science of Spices & Culinary Herbs - Latest Laboratory, Pre-clinical, and Clinical Studies
Proceedings 20 See all (20) →
-
2019 Calorie Restriction Mimetics in Cardiovascular Diseases
-
— Potansiyel Bir Biyobelirteç Olarak Trimetilamin N-oksit
-
2023 Comparison of Drug Information Sources on Levels and Mechanisms of Drug Interactions
-
2024 Proton Pump Inhibitors and Dementia Risk: A Study Based on FAERS Database
-
2019 Probiotics
Collaboration network
From the author lists of YÖKSİS publication records. Duplicate records of a work count once; institutions are co-authors’ current YÖKSİS affiliations.
- Co-authors
- 29
- With an akaturk profile
- 19
- Turkish institutions
- 5
- Co-authored works
- %100
Academic co-authors 19
- CAHİT NACİTARHAN Doçent · Akdeniz Üniversitesi 6
- AYBALA TEMEL Doktor Öğretim Üyesi · İzmir Katip Çelebi Üniversitesi same university 5
- GİZEM KAYKI MUTLU Doktor Öğretim Üyesi · Ankara Üniversitesi 5
- SALİHA AKSUN Profesör · İzmir Katip Çelebi Üniversitesi same university 3
- CÜNEYT KEMAL BUHARALIOĞLU Profesör · İzmir Katip Çelebi Üniversitesi same university 2
- DEVRİM DEMİR DORA Doktor Öğretim Üyesi · Akdeniz Üniversitesi 2
- DİLARA NEMUTLU SAMUR Doktor Öğretim Üyesi · Alanya Alaaddin Keykubat Üniversitesi 2
- MERVE KARPUZ Doçent · İzmir Katip Çelebi Üniversitesi same university 2
- NERGİZ HACER TURGUT Profesör · İzmir Katip Çelebi Üniversitesi same university 2
- ARDA TAŞATARGİL Profesör · Akdeniz Üniversitesi 1
Show all (19)
- AYŞEGÜL ATEŞ DEĞİRMENCİ Araştırma Görevlisi · Ege Üniversitesi 1
- BAŞAK BAĞCI Doktor Öğretim Üyesi · Dokuz Eylül Üniversitesi 1
- ESRA AKCABAĞ Araştırma Görevlisi · Akdeniz Üniversitesi 1
- GÜL ÖZBEY Profesör · Akdeniz Üniversitesi 1
- MELİH KAAN SÖZMEN Profesör · İzmir Katip Çelebi Üniversitesi same university 1
- MURAT AKSUN Profesör · İzmir Katip Çelebi Üniversitesi same university 1
- SADİ SATILMIŞ ÖZDEM Profesör · Akdeniz Üniversitesi 1
- SEBAHAT ÖZDEM Profesör · Akdeniz Üniversitesi 1
- TİJEN TEMİZ Profesör · İzmir Katip Çelebi Üniversitesi same university 1
National collaboration 5 institutions
Within own university10 joint works · İzmir Katip Çelebi Üniversitesi
- Akdeniz Üniversitesi 7 works · 7 academics
- Ankara Üniversitesi 5 works · 1 academics
- Alanya Alaaddin Keykubat Üniversitesi 2 works · 1 academics
- Dokuz Eylül Üniversitesi 1 works · 1 academics
- Ege Üniversitesi 1 works · 1 academics
Other co-authors (incl. international) 10
BETÜL RABİA VADACCA 5Leszek Wojnowski 5Martin C. Michel 5Feride ÖnerMELİKE NUR AKBAŞMuhammetcan SekmanNagihan Altınıcı KarahanOZAN ERBASANZELİHA BAYRAMÇağatay Hasip
Authors without an akaturk profile (international researchers, retired or former academics, students, clinicians) are grouped by name spelling; short forms such as “Gulluce M.” join the single full name they match.